G. Lajoie et al., RENAL THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH MULTICENTRIC CASTLEMANS-DISEASE - REPORT OF 2 CASES, The American journal of surgical pathology, 19(9), 1995, pp. 1021-1028
Castleman's disease (also called giant lymph node hyperplasia or angio
follicular lymph node hyperplasia) is a clinicopathological entity of
unknown etiology. Two histologic patterns of lymph nodes are classical
ly recognized: the hyaline-vascular and plasma-cell variants. Recently
, multicentric Castleman's disease has emerged as a separate clinical
entity manifested primarily by generalized lymphadenopathy and systemi
c manifestations, such as thrombocytopenia, hemolytic anemia, hepatosp
lenomegaly, altered liver function tests, central nervous system alter
ations, and autoimmune manifestations. A number of renal alterations h
ave been described in association with the two pathological variants o
f Castleman's disease, but thrombotic microangiopathy has been previou
sly reported only once in a patient with Castleman's disease, No renal
biopsy was performed in that patient, although there was evidence of
renal dysfunction. We report two cases of biopsy-proven renal thrombot
ic microangiopathy associated with multicentric Castleman's disease. I
n addition to having lymph node pathology characteristic of Castleman'
s disease, both patients presented with generalized lymphadenopathy an
d systemic manifestations, including acute renal failure, hypergammagl
obulinemia, anemia, thrombocytopenia, and hypoalbuminemia. Autoantibod
ies were present in both patients, including antiphospholipid antibodi
es in one patient. The renal biopsies, examined by light, immunofluore
scence, and electron microscopy, were diagnostic for renal thrombotic
microangiopathy. The simultaneous development of two rather uncommon s
yndromes, multicentric Castleman's disease and renal thrombotic microa
ngiopathy, suggests a possible link between Castleman's disease and re
nal thrombotic microangiopathy. Furthermore, we propose that the produ
ction of autoantibodies, in particular antiphospholipid antibodies, ma
y lead to the development of thrombotic microangiopathy in some patien
ts with multicentric Castleman's disease.